Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CMV-CD19 CAR T-cells |
Synonyms | |
Therapy Description |
CMV-CD19 CAR T-cells are CMV-specific T-cells that are engineered to express a chimeric antigen receptor (CAR) targeting CD19, which may stimulate an anti-tumor response against CD19-expressing tumors (PMID: 35027426, PMID: 25838392). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CMV-CD19 CAR T-cells | CD19 Immune Cell Therapy 62 | CMV-CD19 CAR T-cells are CMV-specific T-cells that are engineered to express a chimeric antigen receptor (CAR) targeting CD19, which may stimulate an anti-tumor response against CD19-expressing tumors (PMID: 35027426, PMID: 25838392). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|